Yellowstone Holding AG
Overview
Yellowstone Holding AG is a venture capital firm founded in 2016 that operates as a long-term strategic investor, seeking to invest in Swiss medical technology-related startups with products or technologies ready for commercialization and with growth plans in Asia.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HyperVention | Mar 2022 | VC Round | Lead |
| CUTISS AG | Jun 2018 | Series A | Co-investor |
| Medyria | Jan 2023 | Series B | Lead |
| Hyprevention | Feb 2022 | Series A | Co-investor |
| CryoTherapeutics SA | Apr 2024 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Yellowstone Holding AG based?
Yellowstone Holding AG is headquartered in Geneva, Switzerland.
When was Yellowstone Holding AG founded?
Yellowstone Holding AG was founded in 2016.
How many portfolio companies does Yellowstone Holding AG have?
Yellowstone Holding AG has 5 portfolio companies in Caplight's dataset.
What are some companies in Yellowstone Holding AG's portfolio?
Portfolio companies visible on Caplight include HyperVention, CUTISS AG, Medyria, Hyprevention, CryoTherapeutics SA.
What was Yellowstone Holding AG's most recent investment shown here?
Yellowstone Holding AG's most recent investment in this portfolio sample was in CryoTherapeutics SA in 2024.
What sectors does Yellowstone Holding AG focus on?
Yellowstone Holding AG focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Yellowstone Holding AG focus on?
Yellowstone Holding AG typically invests at the Early stage.